The year in HIV medicine
Abstract number: 1133_56
This session will focus on a discussion on recent publications related to the management of HIV. The following topics will be included: 1. Virology: Evolutionary pathways and how antiretroviral therapy (ART) affects this. Response to ART according to which of the viral subtypes the patient is infected with. 2. Effect of ART: New strategies, newer generation of drugs from the three main drug classes and new drug classes to manage patients harbouring HIV fully susceptible to all types of ART and patients harbouring HIV that has varying degrees of diminished susceptibility. When using ART, setting altered aims than complete viral suppression for patients harbouring HIV with widespread decreased susceptibility. 3. Adverse effects of ART: Emerging knowledge on metabolic toxicities associated with the use of ART. What are the mechanism of actions. Which drugs and drug classes are responsible? Individual patient management. 4. Use of ART in patients co-infected with hepatitis viruses. What is the extend of the problem? Can the hepatitis virus infection be cured? 5. Epidemiology: Assessing the risk of turning a fully drug susceptible HIV epidemic to a multi-drug resistant epidemic from widespread introduction of ART within a population. How effective can the introduction of ART within a population expect to attenuate the risk of transmission. 6. Vaccine development. How effective is the prime-boost approach to enhance anti-HIV cytotoxic T-lymphocyte (CTL) response. Which level of CTL response is required for clinical protection?. A listing of the publications to be reviewed will be available at the start of the session.
|Session name:||XXIst ISTH Congress|
|Back to top|